chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My left upper arm where I got the vaccine abdomen and my face felt very itchy.; My left upper arm where I got the vaccine abdomen and my face felt very itchy.; congestion; fever; headache; felt pain around my upper arm going to my elbow; cough; sore throat; This is a spontaneous report from a contactable consumer (patient).   A 59-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection Batch/Lot number: EN6207, Expiration Date was not reported), via an unspecified route of administration, administered in upper left arm on 12Mar2021 08:40 (at the age of 59-year-old) as 1st dose, single for covid-19 immunisation. The patient medical history included asthma and hypertension. Concomitant medications were not reported. The patient historical vaccine includes second shot of the shingles with a reaction to the second shot and experienced flu shot redness and heat at the injection site. The patient did not receive any prior vaccinations within 4 weeks. On 12Mar2021, the patient experienced Itching of arm, abdomen, and face, congestion, cough, sore throat, headache and fever. She started feeling itchy 45 min after receiving the vaccine. Her left upper arm where she got the vaccine abdomen and her face felt very itchy. She felt pain around her upper arm going to my elbow. Her fever was 1 degree above my normal temperature. Her congestion ended around 19-20th and fever around the 21. She wants to know if she was eligible to receive the second dose of the vaccine. She did not want to get a full blown COVID, she would rather get a weakened case. She states that it would be because of her age, high blood pressure, and asthma. She wants to know if the reactions she had to the PFIZER COVID shot were normal and if they will prevent her from getting the second shot. She was slammed with congestion and a fever that lasted about 10 days. She was taking Benadryl for the itching and it stopped. She also took Tylenol for the fever. She was concerned but went to get tested. The tests were rapid tests, both times. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 14Mar2021, sars-cov-2 test: negative on 17Mar2021. Therapeutic measures were taken as a result of left upper arm where she got the vaccine abdomen and my face felt very itchy, fever. The outcome of the event left upper arm where I got the vaccine abdomen and my face felt very itchy was resolved on 12Mar2021, for congestion it was resolved on 19Mar2021, for fever it was resolved on 21Mar2021 and outcome was unknown for other events.  Information on Lot/Batch number was available. Additional information has been requested.
Burning sensation in stomach, excessive burning symptoms after eating food. Nausea after eating with abdominal pain and burning sensation in the upper stomach.
Delayed Large Local Reaction at left deltoid 1 day after vaccination with tenderness, erythema approx 4 cm diameter circle  No treatment
Information has been received from a registered nurse referring to a 15 month old patient (gender not reported). On 24-FEB-2015 the patient was vaccinated with the first 0.5 ml dose of VARIVAX (Merck) (lot # not reported) subcutaneously and on 03-MAR-2015 the patient was vaccinated with a second 0.5 ml dose of VARIVAX (Merck) subcutaneously. No adverse effects were reported. Additional information has been requested.
Proquad and Varivax given to 12 month old, no adverse reactions at this time.
rash started on both upper arms; slight itchy (rash); This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (rash started on both upper arms) and PRURITUS (slight itchy (rash)) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036L20A) for COVID-19 vaccination.     no medical history provided.  Concomitant products included AMLODIPINE, APIXABAN (ELIQUIS), METOPROLOL SUCCINATE (TOPROL XL), ATORVASTATIN CALCIUM (LIPITOR) and GLYCERYL TRINITRATE (NITROL [GLYCERYL TRINITRATE]) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (rash started on both upper arms) and PRURITUS (slight itchy (rash)). The patient was treated with TRIAMCINOLONE for Itching, at a dose of 1 %. At the time of the report, RASH (rash started on both upper arms) and PRURITUS (slight itchy (rash)) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient felling temporarily better.   This case was linked to MOD-2021-225442 (Patient Link).
pt recvd vax & w/in 3-5 mins exp severe pruritic papular rash w/inc nasal congestion no wheezing but 02 saturation down to 94.9 BP stable recvd DPH, EPI sent to ER; pt recovered w/o problems;
Right arm swollen, red, warm around injection site one week after the shot.  Then bruised.  On 4/8/2021 woke up with swollen upper and bottom lip.  Lips very large.
Received DT and Havrix and developed fever of 102F on 5/15/02, diffuse erythematous rash on 5/19/02 and arthralgias on 5/20/02. Fever resolved on 5/19/02 and rash is resolving but arthralgias still present. Treated with Tylenol and Benadryl. Last DT was 10 years ago with no reaction.
In the Primary Care setting a wrong vaccine order was entered, and an Adult vaccine was administered to a pediatric patient.
pts mom called stating that pt lt thigh was hot & red @ that the pt was upset; mom advised to come in immed-never did f/u mom went elsewhere;
Site: Bruising at Injection Site-Severe, Site: Itching at Injection Site-Severe, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Headache-Severe
PT. STARTED FEELING ITCHY AFTER 15 MIN. OF GETTING HER 2ND DOSE OF MODERNA VACCINATION. PT. WAS GIVEN BENADRYL 50MG BY MOUTH.  THE INDIVIDUAL STAYED IN THE WAITING AREA FOR ANOTHER 30 MIN. THEN STATED SHE WAS FEELING BETTER. FOLLOWED UP WITH PT. IN THE EVENING THE SAME DAY AND THE FOLLOWING DAY. SHE STATED SHE WAS DOING BETTER.
At 1457 client alerted EMT she was dizzy and hearing ringing on both ears. PHN and RN arrived at 1459, client sitting upright on chair, alert and oriented x4, pale, mild diaphoresis. First vitals at 1459: blood pressure 69/54, pulse 56, oxygen sat 99%. At 1500 client transferred to anti-gravity chair with help from EMT. Grandmother present with client, stated no medical history, no medications and no known allergies. Client stated she had ate and hydrated prior to vaccine. Per client felt dizzy from the moment she stood after vaccine administration and still walked to observation room without alerting staff. At 1504: pulse 78, oxygen sat 96%. Vitals at 1505: blood pressure 114/71, pulses 89, oxygen sat 97%. Skin normal for ethnicity, client reported ringing of ears and dizziness improving. Client denied blurry vision, headache, nausea, or shortness of breath.  RN gave client Capri-Sun juice, client began drinking in small sips. Vitals at 1513: blood pressure 100/68, pulse 78, oxygen sat 98%. Client reported dizziness and ringing of ears resolved. EMT placed anti-gravity chair on 45 degree angle, client tolerated well, no complaints. Vitals at 1522: blood pressure 105/61, pulse 72, oxygen sat 98%. Client stated no symptoms at this time. EMT placed anti-gravity chair at 90 degrees, client reported no changes. Last vitals at 1533: blood pressure 107/70, pulse 75, oxygen sat 98%. PHN gave client and client's Grandmother ER precautions and advised to follow up with primary medical provider. PHN asked client to stand up and walk a few steps at 1534. Client walked with no complaints.
Covid monitoring documentation. PT admitted 12/23/21 documented to have positive covid. PT received 1st dose Pfizer 3/18/21 Lot EN6208, and 2nd dose Pfizer 4/8/21 Lot EW0151.
Within 20mins of injection: Right arm tremors and twitching resembling dystonia, brain fog, nausea, extreme thirst, difficult swallowing,  jaw pain, increased heart rate, and fatigue. Drank water and rested. Resolved within 120mins.   After 12 hours if injection: nigh sweats, chills, fatigue, headache, and fatigue. Resolved with 600mg ibuprofen.  After 48 hours of injection: Muscle tightness and twitching, limping, tachycardia, extreme fatigue and loss of strength. (Resembled POTS flare) Drank water, laid down,  and rested. Resolved within 120minutes.
this is one of two hosp employees to devel a 10cm area of swelling, pain, warmth & a nodule @ the site of flu vax;2 days p/vax pt devel nausea & vomiting which persisted for 2 days;pt was seen in the Er & tx w/oral & IM Phenergan;
Bright red rash on arms and legs.  Swollen left wrist.  Was given an IV of steroids in urgent care and a prescription of steroids for 6 days.  Redness has slowly lessened to bruise colored marks.
pt recv vax 1PM & woke crying & very fussy, hard to console temp in ER 102, inj site red & hot to touch, crying lasted 2-3hr;fever 102-103;still red, hot, very tender;
Chills; legs didn't work; hip sore; This is a spontaneous report from a contactable consumer (patient). A 77-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot no.: EL3247) via unspecified route of administration in left arm on 31Jan2021 at 13:00 (age at vaccination 77-year-old) at single dose for COVID-19 immunisation. Medical history, concomitant medications and past drug history were not reported. No other vaccine in four weeks. On 02Feb2021, patient experienced Chills, legs didn't work and hip sore. Reporter states he was calling to report after the vaccine. Three days later, he states he didn't feel good and was starting to have the chill, so he went to bed. After he went to bed he had the chills really bad, even the bed shook, and when he went to get out of bed his legs didn't work. His legs just folded up and he ended up on the floor. He didn't know if he was having a stroke or what. They called an ambulance and went to the ER in (city). At the ER they gave him some fluids and the shakes went down and later his legs came back. Adds his hips, both hips were really sore and he still has a sore spot on one side today. He has never had this problem before. By 14:00 in the afternoon he felt better and he was sent home. The patient adds that they did a CT scan and some other tests. Adds he was told he might have some signs of diverticulitis and he might have bacteria in his blood and he was supposed to call the doctor today to get some medication for that if he does. He was scheduled to receive the second dose on 25Feb2021. Patient mentioned his weight was between 155 pounds and 165 pounds. Adverse event (chills, legs didn't work) resulted in emergency room but not admitted to hospital. The outcome of event for chills, legs didn't work was recovered on 03Feb2021 and hip sore was recovering.
Behavioral changes. Refusing bottle/feeding, sleeping issues (sleeping less), excessive fussiness, irritability.
Information has been received from a physician and a practice manager via two company representatives referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant medication were unknown. On 19-JUL-2016 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 0.5 ml (lot # L010598, expiration date 06-AUG-2016, route unknown). The total cumulative excursion time was 24 hours with the highest recorded temperature of 47 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Client waited 15 min.after Tdap and Hep A inj. before leaving clinic. No adverse effects noted @ this time.Client returned to clinic @ 245pm with wife. Reports driving after shots and experienced increased heart rate and numb tongue.Client called wife who called dr. and advised to go to ER for evaluation. Client declined and came back to clinic with wife. Told client no physician was on staff and should go to ER. CLient declines again. Asked client if still had symptoms as reported earlier. Client states heart rate seems normal and tongue was no longer numb. Asked client if he had or was having symptoms of shortness of breath or breathing difficulties. Client states no but states still "feels weird". Asked client if has PCP, no. Advised client to go to urgent care for evaluation as clinic did not have a physician to evaluate client. Client's wife states will take client to facility for evaluation.
Moderna covid-19 vaccine EUA right arm where the shot was given is painful and swollen, worse the day after. could not sleep because of it hurting. Is this normal? My husband got his vaccine shot at the same time and it did not do this to him.
Severe pain, difficulty sleeping, tingly sensation in legs. In the morning, flu symptoms: fever, chills, fatigue, headache, muscle aches, nausea, vomiting. I had to cancel all my plans and lay in bed.
Severe arthritic episode in left shoulder; This is a spontaneous report from a contactable consumer (patient).    A 42-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 06May2021 13:30 (Batch/Lot Number: EW017q) at 42-years-old as single dose for covid-19 immunisation. Medical history included Arthritis, Tendinitis, Post-traumatic stress disorder (PTSD), Bipolar Depression, ADHD. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Known allergies included Soma, Trazadone. The patient was not pregnant. Historical vaccine included first dose of bnt162b2 (Lot number: ER8735) on 07Apr2021 13:00 at 42-years-old administered in Arm Right for covid-19 immunisation. The patient experienced severe arthritic episode in left shoulder (medically significant) on 10May2021 with outcome of not recovered. No treatment received for the event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Information on Lot/Batch number was available. Additional information has been requested.
Pt had seizure with temp 104. Was taken to hospital. Dx febrile seizure
Headache Right Arm injection site pain and stiffness in right  arm  Narrative:
This marketed literature report has been received from the authors of the published literature article as stated below, concerning a 22-year-old male patient with preB-cell acute lymphoblastic leukemia who underwent myeloablative allogeneic hematopoietic cell transplantation (HCT) from a HLA-identical unrelated donor using a peripheral blood allograft 4 years prior to presentation. His post-HCT course was complicated by acute graft-vs-host disease (GVHD) of the skin, eyes, gastrointestinal tract, and liver requiring intensified immunosuppression with tacrolimus, itacitinib, and prednisone. After clinical resolution of GVHD, all iatrogenic immunosuppression was discontinued on day +1335. Nine days post vaccination, he presented to the Hematology and Oncology Clinic with fevers up to 40°C (104°F), sore throat, nonproductive cough, and tender cervical lymphadenopathy. Twelve days post vaccination, he returned to the Hematology and Oncology Clinic after an asymptomatic, faint pink, maculopapular rash developed on his face and spread to his torso and upper extremities. He did not have conjunctivitis or coryza. He denied any recent measles exposures, sick contacts, or international travel. After consultation with Transplant Infectious Diseases, Clinical Epidemiology and Infection Prevention, and the Public Health, a diagnostic evaluation for vaccine-derived measles (Measles post vaccine) was performed. Serum measles immunoglobulin M antibody was positive and immunoglobulin G antibody was negative. Measles RNA was detected by polymerase chain reaction in urine and throat specimens. Viral genotyping by sequence analysis confirmed the strain to be genotype A (vaccine-derived) measles. He received a single dose of intravenous immunoglobulin (IVIG) 400 mg/kg. His symptoms resolved without sequelae. Despite his attendance at the Hematology and Oncology Clinic where other vulnerable individuals with solid tumor malignancies, hematologic malignancies, and HCT recipients were also present, no secondary cases occurred. The authors considered the event of vaccine-derived measles to be related to the suspect therapy. Upon internal review, the event of Measles post vaccine was considered medically significant.
Fever/Fever; Vomiting; Intense diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever/Fever), VOMITING (Vomiting) and DIARRHOEA (Intense diarrhea) in a 75-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Sep-2021, the patient experienced PYREXIA (Fever/Fever) (seriousness criterion hospitalization), VOMITING (Vomiting) (seriousness criterion hospitalization) and DIARRHOEA (Intense diarrhea) (seriousness criterion hospitalization). The patient was hospitalized until 04-Sep-2021 due to DIARRHOEA, PYREXIA and VOMITING. On 04-Sep-2021, PYREXIA (Fever/Fever), VOMITING (Vomiting) and DIARRHOEA (Intense diarrhea) had resolved.            No concomitant medication was provided. No treatment medication was provided. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-044968 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Flu symptoms for 2 days after. Slight fever, body aches, fatigue, and diarrhea.  2-3 weeks after vaccination (approx 11/2/2021) a phantom smell started (patient smells it but it is not real). The smell comes and goes and varies in strength. Smells like rotting food / sewer. This is on going as of 12/2/2021 and is not improving.
Received 1.0 ml Flu vaccine. Soreness arm for 2 days took Ibuprofen.
EXTREME EXTREME EXTREME fatigue.  No other cause.  My routine, activity, and eating habits were the same as usual during these days.  I slept 10/16/09 from 3pm--10am on 10/17/09.  I continued to sleep on 10/17/09 from 12pm--7pm and then from 7pm--11am 10/18/09.
This case was reported by a lawyer and described the of neoplasm in a female subject of unspecified age who was vaccinated with Lyme disease vaccine recombinant (Lymerix) for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date the subject received unspecified dose of Lymerix (unknown). At an unspecified time after vaccination with Lymerix, the subject experienced a debilitating neoplasm, joint pain particularly in her back, neck, knees, elbows, fingers and jaw, flu-like symptoms, memory loss, fatigue, chest pain, headache, nerve injury, autoimmune disease, and activities of daily living impaired. This case was assessed as medically serious by manufacturer (OMIC). At the time of reporting the outcome of the events were unspecified. This information was received via the statement of injuries.
pt stated their right arm still hurts and continues to be weak at the shoulder joint. dr's did an xray according to pt and they cannot find anything that is causing the pain. pt believes it is from the shot.
ELIMINATE LYME DISEASE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's past medical history included lyme disease. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case.  No concomitant medications were reported.  On an unspecified date, the subject experienced eliminate lyme disease. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of eliminate lyme disease was not reported. This report was non-serious.
Somatic (truncal and extremity) and facial rash with pruritus. Still present.
pt recv vax 27DEC96 & w/in 30min of vax pt devel swelling of eyes & gums, & exp itchiness of eyes & gums;pt was seen in ER & given DPH;
Pt. has chickenpox on 02/13/2012, pt. inmune. Varicella immunization not given.
patient in bed for 2 weeks; sick; Initial information received on 03-Dec-2020 regarding an unsolicited valid serious social media case received from a consumer (patient) via social media.  This case involves a patient of an unknown demographics who was sick (Illness) and in bed for 2 weeks (bedridden), when received INFLUENZA VACCINE.  Medical history, medical treatments, vaccinations, concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) (batch number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed was sick (Illness, non-serious event) (Unknown latency) following the administration of INFLUENZA VACCINE.  On an unknown date, the patient was in bed for 2 weeks (bedridden, serious event) (Unknown latency) following the administration of INFLUENZA VACCINE. This event was leading to disability.  No relevant laboratory tests were reported.  It was not reported if the patient received a corrective treatment.  Events outcome was unknown, at the time of reporting.  Information on the batch number was requested for this case.; Sender's Comments: This case concerns patient who was presented Illness and was bedridden with INFLUENZA VACCINE (produced by unknown manufacturer). The time to onset for both events was unknown. However, patient's medical condition, Laboratory and concomitant medications were ruling out alternate etiologies. Based upon the reported information, the role of the vaccine cannot be assessed.
Breakthrough case admission after 4 vaccines  Pfizer 1/26/21 lot# EL3249;  Pfizer 2/16/21 lot# EN6200;  Pfizer 9/24/21 lot# FF2588;  Pfizer 4/6/22 lot# FK9894
Symptoms included dizziness, headache, nausea, vomiting, diarrhea, and chills. Symptoms started about 30 minutes after receiving the vaccine and lasted approximately 12 hours. Treated symptoms with Tylenol, Pepcid, Zofran, Phenergan, and rest. Symptoms resolved on their own.
Hives/rash appeared and has been getting worse; not itchy, a little sore, mildly swollen, mildly red. It's Inside the elbow and inside L arm toward the wrist and toward armpit, all along the inner arm, Describes them as red uneven and crusty in appearance adv that this type of rash is not likely related to the shot given placement on the opposite arm but concerned for medical issues (ex I'm concerned for shingles possibly, given placement and description of the rash), would adv FU with a HCP first thing in the morning. Provided phone number for follow up if anything worsens tonight and PCC will check back in the morning   4/27-patient calling back, states her symptoms have improved .  caller had mentioned that she was so lethargic for a few days, sx have subsided